Clinical trial
Ancillary Study to Protocol 20060104
NCT00439894 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00439894 |
|---|---|
| Title | Ancillary Study to Protocol 20060104 |
| Official title | Protein Phosphorylation Ancillary Study to Amgen Protocol 20060104: Open Label Study to Assess the Safety and Immunogenicity of Etanercept SFP When Administered to Subjects Diagnosed With Rheumatoid Arthritis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Procedure |
| Interventions | Blood draw |
| Enrollment | 50 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 26, 2007 |
| Last update posted | Mar 21, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: